NEW YORK (GenomeWeb) – Syntekabio, a bioinformatics startup from South Korea, said today that it has closed a ₩12 billion ($11.2 million) Series B round of venture capital. Smilegate Investment led the round, with participation from the Korea Development Bank, Korea Fixed-Income Investment Advisory, The Yozma Group Korea, and previous investor Altos Ventures.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.